Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hulya Ertas"'
Autor:
Metin Doldur, Hulya Ertas Kilic
Publikováno v:
Science Insights Education Frontiers. 15:2149-2173
This study aimed to investigate the effects of the applications conducted in the science center within the scope of the science lesson “Solar System and Beyond” unit of the 7th-grade students in the secondary school, on the perceptions of the stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f02f44e2e6b09f9d704b3fbe50ed916
https://doi.org/10.15354/sief.23.or101
https://doi.org/10.15354/sief.23.or101
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1645-1649
Introduction Hyperprogression is a specific type of response seen with immunotherapy that is observed in all malignancies with a frequency of 9% - 29%, characterized by a rapid increase in tumor burden. Many possible related factors and possible mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33e9510921a56ca69bc8687d5b92f04
https://doi.org/10.1177/10781552221077418
https://doi.org/10.1177/10781552221077418
Publikováno v:
Journal of Outdoor and Environmental Education. 24:19-36
*Ertaş Kılıç, Hülya ( Aksaray, Yazar )
The purpose of this study was to develop and validate a novel scale, the Development and Validation of Out-of-School Learning Environments Perception Scale (OSLEPS), that measures middle school student
The purpose of this study was to develop and validate a novel scale, the Development and Validation of Out-of-School Learning Environments Perception Scale (OSLEPS), that measures middle school student
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e3798a5d683e2246f31c753c387818
https://doi.org/10.1007/s42322-020-00070-7
https://doi.org/10.1007/s42322-020-00070-7
Publikováno v:
World Journal of Gastrointestinal Oncology. 12:1080-1090
The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24b7e7d5bbae39eaa46522345a7be87f
https://doi.org/10.4251/wjgo.v12.i10.1080
https://doi.org/10.4251/wjgo.v12.i10.1080
Autor:
Doldur, Metin, Kilic, Hulya Ertas
Publikováno v:
Science Insights Education Frontiers; Mar2023, Vol. 15 Issue 1, p2149-2173, 25p
Publikováno v:
Postdigital Science and Education, 2(2)
In this article, we introduce a dissensual knowledge production mechanism for the creation and governance of the commons. Rather than seeking a singular truth which is a social construct, producing a bricolage of truths by citizen associations or com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9071594252e7fc1b06e8921a37c802
https://doi.org/10.1007/s42438-019-00067-6
https://doi.org/10.1007/s42438-019-00067-6
Autor:
Ozkan Kanat, Hulya Ertas
Publikováno v:
World Journal of Clinical Oncology
Continuous inhibition of angiogenesis beyond progression is an emerging treatment concept in the management of metastatic colorectal cancer patients with prior bevacizumab exposure. Treatment options include the continuation or reintroduction of beva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664de5ddc9ec825a9e1a391152ecf0bb
http://europepmc.org/articles/PMC6390122
http://europepmc.org/articles/PMC6390122
Publikováno v:
World Journal of Gastrointestinal Oncology
The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66edd2962a0365d0ce722a99b6945a4b
https://pubmed.ncbi.nlm.nih.gov/33133378
https://pubmed.ncbi.nlm.nih.gov/33133378
Publikováno v:
World Journal of Clinical Cases
Human epidermal growth factor receptor 2 (HER2) signaling pathway activation has been identified as a contributor to de novo or acquired resistance to epidermal growth factor receptor (EGFR) inhibitors in a small subset of patients with metastatic co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834c57a2c31476e2e0e86bdd00517459
http://europepmc.org/articles/PMC6163141
http://europepmc.org/articles/PMC6163141
Autor:
Hulya Ertas, Ozkan Kanat
Publikováno v:
World Journal of Gastrointestinal Oncology
Despite the availability of potent chemotherapy regimens, such as 5-fluorouracil, folinic acid, irinotecan, and oxaliplatin (FOLFIRINOX) and nab-paclitaxel plus gemcitabine, treatment outcomes in metastatic pancreatic cancer (PC) remain unsatisfactor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fe02b7f2c4bf4fbea9b2c1fbc07da0
https://doi.org/10.4251/wjgo.v10.i8.202
https://doi.org/10.4251/wjgo.v10.i8.202